• Follow
  • Follow
  • Menu Item

Log in

Start free trial
  • Reports
    • Diagnostic Testing & Emerging Technologies
    • Lab Compliance Advisor
    • Laboratory Industry Report
    • National Lab Reporter
  • Articles
    • Diagnostic Testing and Emerging Technologies
      • DTC-dtet
      • Earnings-dtet
      • Emerging Tests-dtet
      • FDA-dtet
      • G2 Insider-dtet
    • Lab Compliance Advisor
      • Accreditation-lca
      • Brief Your CEO-lca
      • CLIA-lca
      • CMS-lca
      • Coding-lca
      • Compliance Corner-lca
      • Compliance Guidance-lca
      • Compliance Officers-lca
      • Compliance Perspectives-lca
      • Compliance Plans-lca
      • Compliance-lca
      • DOJ-lca
      • Employment-lca
      • Enforcement-lca
      • False Claims-lca
      • FDA-lca
    • Laboratory Industry Report
      • Capital-lir
      • CMS-lir
      • Deals-lir
      • Dx Pipeline-lir
      • Earnings-lir
      • Enforcement-lir
      • FDA-lir
      • Fee Schedules-lir
      • Funding-lir
    • National Lab Reporter
      • Guidelines at a Glance-nir
      • Health care reform-nir
      • HIPAA-nir
      • Labs in Court-nir
      • Legislation-nir
      • News-nir
      • OIG-nir
      • Reimbursement-nir
      • Safety-nir
  • News
  • Industry Perspectives
  • Webinars
  • Store

Diagnostic Testing and Emerging Technologies

LAB COMPLIANCE ADVISOR

LABORATORY INDUSTRY REPORT

NATIONAL LAB REPORTER

CMS Clarifies Rules for IDTF Medicare Billing of Diagnostic Tests

CMS Clarifies Rules for IDTF Medicare Billing of Diagnostic Tests

by Glenn S. Demby | Mar 10, 2023 | Guidelines at a Glance-nir, National Lab Reporter

The agency recently issued new guidance exempting indirect independent diagnostic testing facilities from some requirements.

This content is for Paid Members only.
Login Register
Lab Owner Convicted for $463 Million Genetic Testing Fraud

Lab Owner Convicted for $463 Million Genetic Testing Fraud

by Glenn S. Demby | Jan 19, 2023 | Enforcement-nir, National Lab Reporter

Case is a recent example of the trend toward Medicare schemes involving telehealth, cancer genetic testing, and kickbacks.

This content is for Paid Members only.
Login Register
CGx Testing and Kickbacks Remain Key Enforcement Targets

CGx Testing and Kickbacks Remain Key Enforcement Targets

by Glenn S. Demby, Rachel Muenz | Jan 1, 2023 | Enforcement-lca, Lab Compliance Advisor

In our latest roundup, schemes involving cancer genetic testing and kickbacks remain the most common, but there were some surprises.

This content is for Paid Members only.
Login Register
January 2023 Labs in Court: Two Usual Cases, Two Unusual Ones

January 2023 Labs in Court: Two Usual Cases, Two Unusual Ones

by Glenn S. Demby | Jan 1, 2023 | Lab Compliance Advisor, Labs in Court-lca

Key cases over the last month include a CGx testing kickback scheme, false billing, and violations of a non-compete clause and HIPAA.

This content is for Paid Members only.
Login Register
FY 2022 OIG Enforcement Rebounds—but Recovery Dollars Don’t Show It

FY 2022 OIG Enforcement Rebounds—but Recovery Dollars Don’t Show It

by Glenn S. Demby | Dec 14, 2022 | Enforcement-nir, National Lab Reporter

The agency’s latest report to Congress shows that while enforcement activity is returning to pre-pandemic levels, recoveries are still down.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com